Methods of treatment using ranolazine and related piperazine derivatives
First Claim
Patent Images
1. A method of treating tissues experiencing a physical or chemical insult, said method comprising:
- administering,to protect skeletal muscles against damage resulting from trauma or subsequent to muscle or systemic diseases,to treat shock conditions, orto preserve donor tissues used in transplants, a therapeutically effective amount of a compound of the formula;
##STR2## or a pharmaceutically acceptable ester or acid addition salt thereof, wherein;
R1, R2, R3, R4 and R5 are each independently hydrogen, lower alkyl, lower alkoxy, cyano, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl, lower alkyl sulfonyl, N-optionally substituted alkylamido, except that when R1 is methyl, R4 is not methyl;
orR2 and R3 taken together form --OCH2 O--;
R6, R7, R8, R9 and R10 are each independently hydrogen, lower acyl, aminocarbonylmethyl, cyano, lower alkyl, lower alkoxy, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl, lower alkyl sulfonyl, di-lower alkyl amino;
R6 and R7 together form --CH═
CH--CH═
CH--;
orR7 and R8 together form --OCH2 O--;
R11 and R12 are each independently hydrogen or lower alkyl; and
W is oxygen or sulfur.
6 Assignments
0 Petitions
Accused Products
Abstract
Piperazine derivatives, particularly ranolazine, are useful for treatment of tissues experiencing a physical or chemical insult, and specifically for treating cardioplegia, hypoxic and/or reperfusion injury to cardiac or skeletal muscle or brain tissue, and for use in transplants.
60 Citations
19 Claims
-
1. A method of treating tissues experiencing a physical or chemical insult, said method comprising:
- administering,
to protect skeletal muscles against damage resulting from trauma or subsequent to muscle or systemic diseases, to treat shock conditions, or to preserve donor tissues used in transplants, a therapeutically effective amount of a compound of the formula;
##STR2## or a pharmaceutically acceptable ester or acid addition salt thereof, wherein;R1, R2, R3, R4 and R5 are each independently hydrogen, lower alkyl, lower alkoxy, cyano, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl, lower alkyl sulfonyl, N-optionally substituted alkylamido, except that when R1 is methyl, R4 is not methyl;
orR2 and R3 taken together form --OCH2 O--; R6, R7, R8, R9 and R10 are each independently hydrogen, lower acyl, aminocarbonylmethyl, cyano, lower alkyl, lower alkoxy, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl, lower alkyl sulfonyl, di-lower alkyl amino; R6 and R7 together form --CH═
CH--CH═
CH--;
orR7 and R8 together form --OCH2 O--; R11 and R12 are each independently hydrogen or lower alkyl; and W is oxygen or sulfur. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11)
- administering,
-
12. A perfusion solution for preserving donor tissue for transplantation comprising a therapeutically effective amount, up to 5 mg/ml, of a compound of the formula:
- ##STR3## or a pharmaceutically acceptable ester or acid addition salt thereof, wherein;
R1, R2, R3, R4 and R5 are each independently hydrogen, lower alkyl, lower alkoxy, cyano, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl, lower alkyl sulfonyl, N-optionally substituted alkylamido, except that when R1 is methyl, R4 is not methyl;
orR2 and R3 together form --OCH2 O--; R6, R7, R8, R9 and R10 are each independently hydrogen, lower acyl, aminocarbonylmethyl, cyano, lower alkyl, lower alkoxy, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl, lower alkyl sulfonyl, di-lower alkyl amino; R6 and R7 together form --CH═
CH--CH═
CH--;
orR7 and R8 together form --OCH2 O--; R11 and R12 are each independently hydrogen or lower alkyl; and W is oxygen or sulfur, in a donor tissue perfusion solution carrier. - View Dependent Claims (13, 14, 18, 19)
- ##STR3## or a pharmaceutically acceptable ester or acid addition salt thereof, wherein;
-
15. A method of treating hypoxic injury to skeletal muscle, said method comprising:
- administering to a mammal in need thereof a therapeutically effective amount of a compound of the formula;
##STR4## or a pharmaceutically acceptable ester or acid addition salt thereof, wherein;R1, R2, R3, R4 and R5 are each independently hydrogen, lower alkyl, lower alkoxy, cyano, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl, lower alkyl sulfonyl, N-optionally substituted alkylamido, except that when R1 is methyl, R4 is not methyl;
orR2 and R3 taken together form --OCH2 O--; R6, R7, R8, R9 and R10 are each independently hydrogen, lower acyl, aminocarbonylmethyl, cyano, lower alkyl, lower alkoxy, trifluoromethyl, halo, lower alkylthio, lower alkyl sulfinyl, lower alkyl sulfonyl, di-lower alkyl amino; R6 and R7 together form --CH═
CH--CH═
CH--;
orR7 and R8 together form --OCH2 O--; R11 and R12 are each independently hydrogen or lower alkyl; and W is oxygen or sulfur. - View Dependent Claims (16, 17)
- administering to a mammal in need thereof a therapeutically effective amount of a compound of the formula;
Specification